1.河南中医药大学第一附属医院 郑州 450003
2.河南中医药大学儿科医学院
3.许昌市中医院
4.杭州师范大学附属医院
张霞,女,博士,主任医师
# 丁樱,女,国医大师,教授,主任医师,博士生导师,主要研究方向:中医药防治小儿风湿免疫及肾脏疾病,E-mail:dingying3236@sina.com
纸质出版日期:2023-07-30,
收稿日期:2022-12-31,
移动端阅览
张霞, 徐闪闪, 王龙, 等. 清热止血方联合雷公藤多苷对过敏性紫癜性肾炎血清源性多聚IgA诱导内皮损伤的保护作用及对NF-κB通路的影响[J]. 北京中医药大学学报, 2023,46(7):970-979.
ZHANG Xia, XU Shanshan, WANG Long, et al. Protective effect of
张霞, 徐闪闪, 王龙, 等. 清热止血方联合雷公藤多苷对过敏性紫癜性肾炎血清源性多聚IgA诱导内皮损伤的保护作用及对NF-κB通路的影响[J]. 北京中医药大学学报, 2023,46(7):970-979. DOI: 10.3969/j.issn.1006-2157.2023.07.014.
ZHANG Xia, XU Shanshan, WANG Long, et al. Protective effect of
目的
2
探讨清热止血方联合雷公藤多苷对过敏性紫癜性肾炎患者血清源性多聚IgA诱导内皮损伤的保护作用及对NF-κB信号通路关键蛋白表达的影响。
方法
2
本研究共纳入就诊于河南中医药大学第一附属医院的80例过敏性紫癜性肾炎患者及38名健康对照者,分别收集血清,将血清IgA纯化,以制备血清源性多聚IgA。将60只SD大鼠按照随机数字表法分为清热止血方组(31.25 mg/kg)、雷公藤多苷组(46.88 mg/kg)、清热止血方联合雷公藤多苷组(31.25 mg/kg+46.88 mg/kg)、醋酸泼尼松组(23.44 mg/kg)、生理盐水组,每组12只,灌胃2次/d,连续7 d。采用过敏性紫癜性肾炎患者血清源性多聚IgA(200 mg/L)刺激人脐静脉内皮细胞24 h,以构建人脐静脉内皮细胞损伤模型。将造模成功的一部分细胞分为模型组、清热止血方组、雷公藤多苷组、清热止血方联合雷公藤多苷组、醋酸泼尼松组及生理盐水组,另设空白组及健康组,并给予相应干预。另一部分造模成功的细胞采用siRNA转染抑制NF-κB信号通路,并将转染后的细胞分为模型+转染组、清热止血方组、雷公藤多苷组、清热止血方联合雷公藤多苷组及醋酸泼尼松组,另设空白组、模型组、模型+正常组,并给予相应干预。采用MTT法检测各组细胞活力,流式细胞术检测各组细胞凋亡率,蛋白质印迹法分别检测转染前后细胞磷酸化的核因子-P65(p-P65)、磷酸化的核因子-P50(p-P50)、核转录因子-κB激酶β(IKKβ)及核转录因子-κB抑制蛋白α(IκBα)的蛋白表达情况。
结果
2
与空白组比较,模型组细胞活力减弱(
P
<
0.05);与模型组比较,各给药组细胞活力增强(
P
<
0.05);与清热止血方联合雷公藤多苷组比较,清热止血方组、雷公藤多苷组、醋酸泼尼松组细胞活力减弱(
P
<
0.05)。与空白组比较,模型组细胞p-P65、p-P50及IKKβ蛋白的表达量升高(
P
<
0.05),IκBα蛋白表达量降低(
P
<
0.05)。与模型组比较,各给药组细胞p-P65、p-P50及IKKβ蛋白表达量均降低(
P
<
0.05);而IκBα的表达量升高(
P
<
0.05)。与清热止血方联合雷公藤多苷组比较,清热止血方组、雷公藤多苷组、醋酸泼尼松组p-P65、p-P50及IKKβ蛋白的表达量升高(
P
<
0.05),而IκBα的表达量降低(
P
<
0.05)。siRNA转染后,与空白组比较,模型组、模型+正常组细胞p-P65、p-P50及IKKβ蛋白的表达量升高(
P
<
0.05),IκBα蛋白表达量降低(
P
<
0.05)。与模型组比较,模型+转染组、清热止血方组、雷公藤多苷组、清热止血方联合雷公藤多苷组、醋酸泼尼松组细胞p-P65、p-P50及IKKβ蛋白表达量降低(
P
<
0.05),IκBα蛋白表达量升高(
P
<
0.05)。
结论
2
清热止血方联合雷公藤多苷可能是通过抑制NF-κB通路的活化,进而提高过敏性紫癜性肾炎患者血清源性多聚IgA诱导的人脐静脉内皮细胞的活力,以发挥对内皮细胞的保护作用。
Objective
2
We aimed to explore the protective effect of
Qingre Zhixue
Formula and tripterygium wilfordii multiglucoside on the endothelial damage induced by serum-derived poly IgA in patients with Henoch-Schönlein purpura nephritis and its effect on the expression of key proteins of the NF-κB signaling pathway.
Methods
2
A total of 80 patients with Henoch-Schönlein purpura nephritis from The First Affliated Hospital of Henan University of Chinese Medicine and 38 healthy controls were enrolled in this study. Serum IgA was purified from all participants in order to prepare serum-derived poly IgA. Moreover
60 Sprague-Dawley rats were divided into the following five groups (
n
=12 rats per group): the
Qingre Zhixue
Formula group (31.25 mg/kg)
the tripterygium wilfordii multiglucoside group (46.88 mg/kg)
the combined group (31.25 mg/kg + 46.88 mg/kg)
the prednisone acetate group (23.44 mg/kg) and the saline group. Rats in each group were gavaged twice a day for 7 days. Additionally
human umbilical vein endothelial cells (HUVECs) were stimulated with serum-derived poly IgA (200 μg/mL) derived from patients with Henoch-Schönlein purpura nephritis for 24 h to construct HUVECs injury model. The cells were divided into the following seven groups: the blank group
the healthy group
the model group
the
Qingre Zhixue
Formula group
the tripterygium wilfordii multiglucoside group
the combined group and the prednisone acetate group
and provide corresponding intervention. siRNA transfection was used to inhibit the NF-κB signaling pathway
and divide the transfected cells into the blank group
the model group
the model+ normal control group
the model+ transfection group
the
Qingre Zhixue
Formula group
the tripterygium wilfordii multiglucoside group
the combined group and the prednisone acetate group. Cell viability was detected by the MTT assay
the apoptosis rate was detected by flow cytometry
and the protein expression levels of p-P65
p-P50
IKKβ
and IκBα were detected by Western blotting before and after transfection.
Results
2
Compared with the blank group
the cell viability of the model group was decreased (
P
<
0.05). Compared with the model group
the cell viability of each treatment group was increased (
P
<
0.05). Compared with the combined group
the cell viability of the
Qingre Zhixue
Formula group
the tripterygium wilfordii multiglucoside group
and the prednisone acetate group was decreased (
P
<
0.05). Compared with the blank group
the protein expression levels of p-P65
p-P50 and IKKβ in the model group were increased (
P
<
0.05)
and the protein expression level of IκBα was decreased (
P
<
0.05). Compared with the model group
the protein expression levels of p-P65
p-P50 and IKKβ were decreased in each group (
P
<
0.05)
and the protein expression level of IκBα was increased (
P
<
0.05). Compared with the combined group
the protein expression levels of p-P65
p-P50
and IKKβ in the
Qingre Zhixue
Formula group
the tripterygium wilfordii multiglucoside group and the prednisone acetate group were increased (
P
<
0.05)
while the protein expression level of IκBα was decreased (
P
<
0.05). After siRNA transfection
compared with the blank group
the protein expression levels of p-P65
p-P50 and IKKβ in the model group and the model+ normal control group were increased (
P
<
0.05)
and the protein expression level of IκBα was decreased (
P
<
0.05). Compared with the model group
the protein expression levels of p-P65
p-P50 and IKKβ were decreased (
P
<
0.05)
and the protein expression level of IκBα was increased (
P
<
0.05) in the cells of the model+ transfection group
the
Qingre Zhixue
Formula group
the tripterygium wilfordii multiglucoside group
the combined group and the prednisone acetate group.
Conclusion
2
Qingre Zhixue
Formula combined with tripterygium wilfordii multiglucoside may inhibit the activation of the NF-κB pathway to improve the cell viability of HUVECs induced by serum-derived poly IgA in children with Henoch-Schönlein purpura nephritis
so it plays a role in protecting endothelial cells.
过敏性紫癜性肾炎清热止血方雷公藤多苷人脐静脉内皮细胞核转录因子-κB通路
Henoch-Schönlein purpura nephritisQingre Zhixue Formulatripterygium wilfordii multiglucosidehuman umbilical vein endothelial cellsNF-κB pathway
PERUZZI L, COPPO R. IgA vasculitis nephritis in children and adults: one or different entities?[J].Pediatr Nephrol,2021,36(9):2615-2625.
GRIFFIN MJ. On the Immunometabolic Role of NF-kappaB in Adipocytes[J/OL]. Immunometabolism,2022,4(1):e220003[2022-10-25].https://journals.lww.com/immunometabolism/Abstract/2022/01000/On_the_Immunometabolic_Role_of_NF__B_in_Adipocytes.3.aspx.
刘小波,桑文涛,石博宇,等.荆防药对正丁醇提取部位抗炎作用的NF-κB信号通路机制研究[J].北京中医药大学学报,2018,41(11):959-968.
费文君,袁丽萍,鹿玲,等.鬼针草总黄酮对过敏性紫癜患儿血清IgA1诱导血管内皮细胞损伤的保护作用[J].中国中西医结合杂志,2016,36(2):183-187.
胡明格,李雪军,杜梦珂,等.丁樱教授治疗儿童肾性血尿经验探析[J].中国中西医结合儿科学,2020,12(4):345-348.
王龙,徐闪闪,代彦林,等.雷公藤多苷片联合清热止血方对紫癜性肾炎患者的临床疗效[J].中成药,2021,43(4):914-918.
徐闪闪,王龙,张霞,等.清热止血方联合雷公藤多苷治疗儿童紫癜性肾炎临床疗效及对Gd-IgA1影响的研究[J].时珍国医国药,2020,31(4):883-886.
中华医学会儿科学分会肾脏学组.紫癜性肾炎诊治循证指南(2016)[J].中华儿科杂志,2017,55(9):647-651.
REAMY BV, SERVEY JT, WILLIAMS PM.Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review[J].Am Fam Physician,2020,102(4):229-233.
DING Y, ZHANG X, REN XQ,et al.Traditional Chinese medicine versus regular therapy in Henoch-Schonlein purpura nephritis in children: study protocol for a randomized controlled trial[J/OL]. Trials, 2019,20(1):538[2022-10-25]. https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3484-3.
GOLDSTEIN AR, WHITE RH, AKUSE R,et al.Long-term follow-up of childhood Henoch-Schonlein nephritis[J].Lancet,1992,339(8788):280-282.
中华医学会儿科学分会肾脏病学组.儿童常见肾脏疾病诊治循证指南(二):紫癜性肾炎的诊治循证指南(试行) [J].中华儿科杂志,2009,47(12):911-913.
FERRARA G, PETRILLO MG, GIANI T, et al. Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age [J/OL]. Int J Mol Sci, 2019, 20(2):444[2022-10-25]. https://www.mdpi.com/1422-0067/20/2/444.
PONTICELLI C, GLASSOCK RJ. Prevention of complications from use of conventional immunosuppressants: a critical review [J]. J Nephrol, 2019, 32(6): 851-870.
丁樱,吴力群,黄可丹.血尿停颗粒剂联合雷公藤多甙片治疗小儿紫癜性肾炎30例[J].上海中医药杂志,2004,38(8):37-38.
任献青,丁樱,翟文生.雷公藤多甙联合肝素钠治疗儿童过敏性紫癜性肾炎76例 [J]. 中医研究,2008, 21(5):24-25.
郑贵珍.不同剂量雷公藤多甙片配合中药治疗小儿紫癜性肾炎血尿的疗效和安全性[D].郑州:河南中医药大学,2007.
NEUFELD M, MOLYNEUX K, PAPPELBAUM KI, et al. Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis[J]. J Am Acad Dermatol,2019,81(5):1078-1085.
ALLEN AC, WILLIS FR, BEATTIE TJ, et al. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis [J]. Nephrol Dial Transplant, 1998, 13(4): 930-934.
GROZA Y, JEMELKOVA J, KAFKOVA LR, et al. IL-6 and its role in IgA nephropathy development[J].Cytokine Growth Factor Rev,2022,66:1-14.
徐闪闪,王龙,丁樱,等.基于核转录因子-κB信号通路探讨清热止血方联合雷公藤多苷治疗紫癜性肾炎大鼠的作用机制[J].中华中医药杂志,2022,37(5):2881-2886.
王嘉文,宋璐,詹华奎.补肾活血祛风方对阿霉素肾病大鼠肾组织NF-κB及IL-18水平的干预研究[J].北京中医药大学学报,2021,44(11):1011-1019.
吴琳,袁丽萍,费文君,等.过敏性紫癜患儿血清对人脐静脉内皮细胞的影响及甲基泼尼松龙的保护作用[J].中国当代儿科杂志,2012,14(1): 59-63.
冯晓异,赵微,何朋伦,等.三七总皂苷调节iNOS-NO-NF-κB信号通路抑制LPS诱导的RAW246.7细胞炎症研究[J].药物评价研究,2020,43(4):670-675.
范彦芳,李前宽,周晓慧,等.丹皮酚、三七总皂苷联合应用对心梗后心室重构大鼠心肌组织NF-κB p65、TNF-α表达的影响[J].承德医学院学报,2017,34(4):271-273.
张璇,姜睿斌,张晓菊,等.基于NF-κB通路研究生地黄-玄参对糖尿病肾病大鼠肾脏微炎症状态的影响[J].国际中医中药杂志,2022,44(1):49-55.
胡姮,邹志红,张刚成.赤芍总苷通过NF-κB通路对慢阻肺大鼠肺组织炎症及凋亡的作用研究[J].湖北中医药大学学报,2022,24(3):16-20.
刘冬华,姚震,蒋鹏飞,等.补虚活血中药枸杞子丹参对rd10小鼠视网膜小胶质细胞NF-κB通路的影响[J].时珍国医国药,2022,33(3):533-536.
张敏,王守安,刘黎星.雷公藤多苷干预TLR-NF-κB通路发挥免疫抑制作用[J].中草药,2014,45(9):1288-1292.
孙贝贝,陈雪梅,王烁阳,等. 雷公藤甲素调节NF-κB通路对脓毒血症大鼠心肌损伤的保护作用[J]. 中国病理生理杂志,2021,37(3):458-465.
盛磊,李歆,饶辉,等. 雷公藤红素下调NF-κB信号通路延缓肝细胞癌发生的作用研究[J]. 世界科学技术—中医药现代化,2021,23(7):2372-2379.
0
浏览量
32
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构